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Objectives: This study aimed to compare the ability of
linezolid and vancomycin to prevent the clinical methicillin-
resistant Staphylococcus aureus (MRSA) resistant mutant by
determining mutant prevention concentration (MPC).
Methods: Fifty-six clinical MRSA isolates were enriched
in broth, and the bacterial concentration was adjusted
to 1010 CFU/mL for MPC determination. Wild-type strains
and mutant strains selected by vancomycin during MPC
determination were characterized by pulsed-ﬁeld gel
electrophoresis (PFGE), Sau-PCR assay, denaturing gradient
gel electrophoresis (DGGE), scanning electron microscopy
(SEM), and transmission electron microscopy (TEM).
Results: Our results showed that both linezolid and
vancomycin might have great ability to restrict the selection
of resistant mutants of MRSA. Linezolid had a narrower
mutant selection window against the MRSA isolates than
vancomycin. Sau-PCR assay and PFGE revealed that pre-
scanning and post-scanning strains selected by vancomycin
during the experimental process of MPC had different DNA
proﬁles. TEM and SEM showed that the mutant strains
had slightly thicker cell walls than the wild-type strains.
DDGE was used to probe for mutations in the graS gene,
but no different banding patterns were observed on the
electrophoretogram spectrum.
Conclusion: Linezolid showed greater ability to restrict the
selection of resistant mutants of MRSA than vancomycin. In
wild-type strains and mutant strains selected by vancomycin
during the experimental process of MPC, there may be
mutations in genes other than the graS gene or existence
of other resistant mechanisms.
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Objectives: Methicillin-resistant Staphylococcus aureus
(MRSA) prolongs hospitalisation and leads to poorer clinical
outcomes. We aim to evaluate risk factors for MRSA
incidence among inpatients at Tan Tock Seng Hospital
(TTSH), Singapore.
Methods: We conducted a retrospective case control study
of 1200 inpatients from January to December 2006 with a
S. aureus clinical culture. 600 cases were randomly selected
from patients with a positive MRSA clinical culture for the
ﬁrst time, and 600 controls with a positive methicillin-
sensitive S. aureus (MSSA) clinical culture without a positive
MRSA in the last 5 years.
Results: MRSA patients were older (median age 69 vs. 55
years, p = 0.000), and more likely to be Chinese than MSSA
patients (OR 2.0, 95%CI 1.6 2.7, p = 0.000). On univariate
analysis, hospitalisation in the preceding year (OR 4.5, 95%CI
3.5 5.8, p = 0.000), presence of a percutaneous device (OR
2.9, 95%CI 2.3 3.8; p = 0.000), use of a cephalosporin (OR
6.4, 95%CI 4.8 8.6, p = 0.000) and use of a ﬂuoroquinolone
(OR 11.8, 95%CI 6.9 21.5, p = 0.000), use of a carbapenam
(OR 20.5, 95%CI 8.3 64.9, p = 0.000) and hospital stay 5
days prior to positive culture (OR 11.8, 95%CI 8.3 17.0,
p= 0.000) were found to be signiﬁcantly associated with
MRSA positivity. On multivariate analysis, history of cardiac
disease (adjusted OR 2.5, 95% CI 1.1 5.7, p = 0.033),
alcohol abuse (adjusted OR 6.1, 95%CI 1.2 31.1, p = 0.03),
ﬂuoroquinolone use (adjusted OR 29.7, 95%CI 3.0 291.5,
p = 0.004), and hospital stay 5 days (adjusted OR 6.7,
95%CI 2.1 21.5, p = 0.001) were independent predictors of
MRSA.
Conclusion: A history of cardiac disease, alcohol abuse,
prior ﬂouroquinolone use, and hospital stay 5 days prior
to positive culture were independent risk factors of MRSA
incidence among inpatients at TTSH. Infection control
measures such as early screening and contact precautions
for high-risk patients should be considered.
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Background: Most skin infections are attributed to Gram
positive cocci like Staphylococcus aureus. Nowadays the
increasing involvement of other bacteria is noticed,
particularly Gram-negative bacteria.
Objective: To establish bacterial species involved in skin
infections and their resistance to antibiotics.
Methods: We analysed the susceptibility tests for the
bacterial strains isolated from skin and soft tissue infections
from patients hospitalized in the Matei Bals National
Institute over a twelve-month period (July 2008 to
June 2009). The susceptibility tests were carried out
using semiautomatic methods (Microscan, Vitek, API, disk
diffusion).
Results: We analysed 252 bacterial isolates: 134 strains of
Staphylococcus aureus (53.17%), 41 strains of Pseudomonas
aeruginosa (16.26%), 47 strains of Enterobacteriaceae
(18.65%), 10 strains of Acinetobacter baumannii (3.96%), 8
strains of Enterococcus spp. (3.17%), 11 strains of other GNB
(4.36%). 35% of Staphylococcus aureus isolates were MRSA.
Staphylococcus aureus showed high levels of resistance
to: macrolides 44% and tetracycline 48.5%. Staphylococcus
susceptibility remains good for ﬂuorquinolones 94.77%;
rifampicin 92.53%; cotrimoxazole 97.7%; chloramphenicol
91.8%. There were no strains resistant to vancomycin and
linezolid.
The level of antibiotic resistance of Pseudomonas
aeruginosa strains is high: ﬂuoroquinolones 60.9%;
cefepime 57.5%; ceftazidim 48.78%; imipenem 42.5%;
piperacillin/tazobactam 42.5%.
In addition, we noticed an important number of
Klebsiella spp. and E. coli strains resistant to
cephalosporins, including cefepime (8/11 strains and 7/20
strains respectively), 2 strains of Klebsiella spp. resistant
